Instrument/Protocol

Helps clinicians better identify the presence of opioid abuse or dependence in patients with chronic pain.

Assesses patients' locations and severity of pain.

Gives a sample naloxone prescription program reporting form to be entered into the patient record or chart or given to the primary care provider.

Assesses risk for addiction to opioids used to treat chronic pain with a 28-item questionnaire specifically designed for general practitioners.

Assesses frequency of use and abuse of substances (e.g., alcohol, tobacco, prescription and illegal drugs, and controlled medications) to determine if an intervention is needed.

Assesses risk for opioid abuse among individuals prescribed opioids for treatment of chronic pain with a brief self-report screening tool designed for use with adult patients in primary care settings. Patients categorized as high risk are at increased likelihood of future abusive drug-related behavior.

Identifies individuals who have a high probability of having an SUD.

Provides a template to track inventory of stock buprenorphine supplies, including patient, quantity dispensed, and manufacturer and lot number.

Assesses perception of one's capacity to refrain from attempting suicide with a 6-item assessment that rates items on a 10-point scale ranging from 0 (very uncertain) to 9 (very certain).

Assesses patients' treatment needs and whether they would be good candidates for office-based opioid treatment.